Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica

被引：0
|
作者：
Araki, M. [1 ]
Matsuoka, T. [1 ]
Aranami, T. [1 ]
Nakamura, M. [1 ]
Okamoto, T. [1 ]
Murata, M. [1 ]
Miyake, S. [1 ]
Yamamura, T. [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [1] Immunomodulatory effect of anti-IL6 receptor monoclonal antibody tocilizumab in patients with neuromyelitis optica
    Matsuoka, T.
    Chiba, A.
    Aranami, T.
    Araki, M.
    Nakamura, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 463 - 464
  • [2] Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica
    Araki, Manabu
    Matsuoka, Takako
    Aranami, Toshimasa
    Nakamura, Masakazu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Yamamura, Takashi
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 911 - 912
  • [3] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab for the treatment of neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 947 - 947
  • [4] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab in three patients with neuromyelitis optica
    Araki, M.
    Aranami, T.
    Matsuoka, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 417 - 417
  • [5] How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?
    Matsuoka, T.
    Araki, M.
    Yamaguchi, H.
    Sato, W.
    Miyamoto, K.
    Kusunoki, S.
    Gold, R.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1000 - 1001
  • [6] Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
    Araki, Manabu
    Aranami, Toshimasa
    Matsuoka, Takako
    Nakamura, Masakazu
    Miyake, Sachiko
    Yamamura, Takashi
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 827 - 831
  • [7] Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
    Araki, Manabu
    Matsuoka, Takako
    Miyamoto, Katsuichi
    Kusunoki, Susumu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Aranami, Toshimasa
    Yamamura, Takashi
    NEUROLOGY, 2014, 82 (15) : 1302 - 1306
  • [8] Anti-IL6 Receptor Monoclonal Antibody Therapy in NMOSD
    Araki, Manabu
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 436 - 436
  • [9] Radiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody.
    Aoki, Chie
    Inaba, Yutaka
    Imagawa, Tomoyuki
    Miyamae, Takako
    Mori, Masaaki
    Saito, Tomoyuki
    Yokota, Shumpei
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1031 - S1032
  • [10] Anti-IL6 Receptor Monoclonal Antibody Therapy in NMO. Takashi Yamamura (Japan)
    Yamamura, Takashi
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 396 - 396
12345